ArticleMolecular therapy : the journal of the American Society of Gene Therapy2011

Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis.

Kazuhiko Matsuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.